KOAN adds 2 key advisors “
Albert Richards & Colleen Quinn
On April 28, 2021, we executed an agreement to bring on Albert Richards, PhD, CFA, as an Advisor responsible for investment strategies and Mergers & Acquisition guidance.
Mr. Richards is a 20-year veteran of the financial services industry. Before starting Alambic Investment Management to develop systematic stock selection strategies, he perfected the art of tearing apart financial statements to find value and opportunity. As a sell-side analyst and head of research within two large global investment banks, Bert became adept at identifying and quantifying the key drivers of equity valuation and company quality as well as the behavioral pitfalls that create market opportunities.
Prior to becoming a founding partner of Alambic, Bert was Managing Director and Head of European Equity Research (1994-2000) for Citigroup (previously Salomon Brothers), European Internet and Global Technology strategist (2000-2003) and Small and Mid-Cap strategist (2003-2006). From 1986 to 1994 Mr. Richards worked in equity research for Credit Suisse First Boston in New York and London.
Mr. Richards received his B.S. in Chemical Engineering from Iowa State University in 1981, an M.S. in Chemical Engineering from MIT in 1983, a Ph.D. degree in Chemical Engineering from MIT in 1986, and an M.B.A. from the Sloan School of Management (MIT), also in 1986. He was awarded the Chartered Financial Analyst.
On May 11, 2021, we added Colleen Quinn as an Advisor in support of product research activities and consumer education programs. Ms. Quinn is an internationally celebrated clinical aromatherapist, cosmetic chemist, and researcher. She specializes in cannabis research, formulations and education.
Committed to delivering functional therapeutic plant-based products, Ms. Quinn has travelled the globe on a quest for knowledge, innovation and the best quality ingredients from dedicated sustainable farmers in order to create therapeutic benefits in skin and health care. She is constantly pushing back the boundaries of her knowledge and skill. The DNA of plants is of consuming interest for her and she derives satisfaction from exploring the chemistry of new ingredient pairings which create new and enhanced synergistic impacts. She has a particular interest in educating on the health benefits of essential oils and cannabis in the treatment of a wide array of conditions.
AI
